Tuomas Mirtti

5.3k total citations
127 papers, 3.0k citations indexed

About

Tuomas Mirtti is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Tuomas Mirtti has authored 127 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Pulmonary and Respiratory Medicine, 43 papers in Molecular Biology and 35 papers in Oncology. Recurrent topics in Tuomas Mirtti's work include Prostate Cancer Treatment and Research (49 papers), Prostate Cancer Diagnosis and Treatment (26 papers) and Bladder and Urothelial Cancer Treatments (24 papers). Tuomas Mirtti is often cited by papers focused on Prostate Cancer Treatment and Research (49 papers), Prostate Cancer Diagnosis and Treatment (26 papers) and Bladder and Urothelial Cancer Treatments (24 papers). Tuomas Mirtti collaborates with scholars based in Finland, United States and Sweden. Tuomas Mirtti's co-authors include Antti Rannikko, Olli Kallioniemi, Kalle Alanen, Peter J. Boström, Marja T. Nevalainen, Kristiina Iljin, Paula Vainio, Johan Lundin, Stig Nordling and Matthias Nees and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The EMBO Journal.

In The Last Decade

Tuomas Mirtti

116 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tuomas Mirtti Finland	29	1.6k	1.1k	825	718	431	127	3.0k
Georg Schäfer Austria	36	1.6k 1.0×	1.2k 1.2×	587 0.7×	717 1.0×	408 0.9×	91	3.3k
Shinichi Sakamoto Japan	30	1.4k 0.9×	799 0.8×	545 0.7×	805 1.1×	469 1.1×	197	3.3k
Dongfeng Tan United States	37	1.9k 1.2×	901 0.9×	1.6k 1.9×	897 1.2×	772 1.8×	124	4.0k
Junichi Inokuchi Japan	28	1.1k 0.7×	1.0k 1.0×	478 0.6×	533 0.7×	401 0.9×	161	2.4k
Caigang Liu China	26	1.4k 0.9×	531 0.5×	850 1.0×	877 1.2×	324 0.8×	132	2.7k
Yoon‐La Choi South Korea	35	1.4k 0.9×	930 0.9×	1.6k 1.9×	1.1k 1.5×	372 0.9×	125	3.7k
Peter Bugert Germany	32	2.1k 1.3×	1.4k 1.3×	479 0.6×	1.1k 1.5×	441 1.0×	147	3.8k
Richard Flavin Ireland	31	2.0k 1.3×	822 0.8×	763 0.9×	1.6k 2.3×	293 0.7×	90	3.6k
Zhongwu Li China	30	1.2k 0.7×	969 0.9×	1.7k 2.0×	683 1.0×	665 1.5×	177	3.4k
Eric Santoni‐Rugiu Denmark	35	1.7k 1.1×	757 0.7×	1.2k 1.4×	681 0.9×	524 1.2×	108	3.3k

Countries citing papers authored by Tuomas Mirtti

Since Specialization

Citations

This map shows the geographic impact of Tuomas Mirtti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tuomas Mirtti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tuomas Mirtti more than expected).

Fields of papers citing papers by Tuomas Mirtti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tuomas Mirtti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tuomas Mirtti. The network helps show where Tuomas Mirtti may publish in the future.

Co-authorship network of co-authors of Tuomas Mirtti

This figure shows the co-authorship network connecting the top 25 collaborators of Tuomas Mirtti. A scholar is included among the top collaborators of Tuomas Mirtti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tuomas Mirtti. Tuomas Mirtti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Corredor, Germán, Elizabeth M. Genega, Omar Y. Mian, et al.. (2025). AI-informed computational pathology classifier predicts outcomes across treatment modalities in muscle-invasive urothelial carcinoma. Cancer Letters. 634. 218059–218059.

Schmotz, Constanze, Annika Hau, Eero Lehtonen, et al.. (2025). Integrin Trafficking, Fibronectin Architecture, and Glomerular Injury upon Adiponectin Receptor 1 Depletion. Journal of the American Society of Nephrology. 36(5). 825–844. 1 indexed citations

Hellsten, Rebecka, Agnieszka Krzyzanowska, Margareta Persson, et al.. (2024). pSTAT3 Expression is Increased in Advanced Prostate Cancer in Post‐Initiation of Androgen Deprivation Therapy. The Prostate. 85(3). 252–264.

Koyuncu, Can, Andrew Janowczyk, Xavier Farré, et al.. (2023). Visual Assessment of 2-Dimensional Levels Within 3-Dimensional Pathology Data Sets of Prostate Needle Biopsies Reveals Substantial Spatial Heterogeneity. Laboratory Investigation. 103(12). 100265–100265. 3 indexed citations

Lee, Moon Hee, Jani Huuhtanen, Petrus Järvinen, et al.. (2023). Immunologic Characterization and T cell Receptor Repertoires of Expanded Tumor-infiltrating Lymphocytes in Patients with Renal Cell Carcinoma. Cancer Research Communications. 3(7). 1260–1276. 6 indexed citations

Liu, Jonathan, Richard Colling, Michelle R. Downes, et al.. (2023). Engineering the future of 3D pathology. The Journal of Pathology Clinical Research. 10(1). e347–e347. 6 indexed citations

Pellinen, Teijo, Sami Blom, Riku Turkki, et al.. (2022). Stromal FAP Expression is Associated with MRI Visibility and Patient Survival in Prostate Cancer. Cancer Research Communications. 2(3). 172–181. 6 indexed citations

Stranne, Johan, Eva Johansson, Matteo Bottai, et al.. (2022). Characteristics of Patients in SPCG-15—A Randomized Trial Comparing Radical Prostatectomy with Primary Radiotherapy plus Androgen Deprivation Therapy in Men with Locally Advanced Prostate Cancer. European Urology Open Science. 41. 63–73. 7 indexed citations

Löyttyniemi, Eliisa, et al.. (2021). Prognostic and predictive value of ALDH1, SOX2 and SSEA-4 in bladder cancer. Scientific Reports. 11(1). 13684–13684. 7 indexed citations

10.

Rannikko, Antti, Tuomas Mirtti, Teemu Tolonen, et al.. (2021). Population‐based randomized trial of screening for clinically significant prostate cancer ProScreen: a pilot study. British Journal of Urology. 130(2). 193–199. 12 indexed citations

11.

Avenel, Christophe, Kimmo Kartasalo, Maja Marklund, et al.. (2021). Morphological Features Extracted by AI Associated with Spatial Transcriptomics in Prostate Cancer. Cancers. 13(19). 4837–4837. 20 indexed citations

12.

Polianskyte-Prause, Zydrune, Eero Lehtonen, Harry Nísen, et al.. (2021). Adiponectin receptor agonist AdipoRon ameliorates renal inflammation in diet-induced obese mice and endotoxin-treated human glomeruli ex vivo. Diabetologia. 64(8). 1866–1879. 37 indexed citations

13.

Zafar, Sadia, Dafne C.A. Quixabeira, João M. Santos, et al.. (2020). Oncolytic Adenovirus Type 3 Coding for CD40L Facilitates Dendritic Cell Therapy of Prostate Cancer in Humanized Mice and Patient Samples. Human Gene Therapy. 32(3-4). 192–202. 21 indexed citations

14.

Hoang, David T., Lei Gu, Andrew Erickson, et al.. (2019). Enzalutamide-Induced Feed-Forward Signaling Loop Promotes Therapy-Resistant Prostate Cancer Growth Providing an Exploitable Molecular Target for Jak2 Inhibitors. Molecular Cancer Therapeutics. 19(1). 231–246. 21 indexed citations

15.

Saeed, Khalid, Teijo Pellinen, Samuli Eldfors, et al.. (2018). Clonal heterogeneity influences drug responsiveness in renal cancer assessed by ex vivo drug testing of multiple patient‐derived cancer cells. International Journal of Cancer. 144(6). 1356–1366. 26 indexed citations

16.

Järvinen, Petrus, et al.. (2018). Patient Experience of Systematic Versus Fusion Prostate Biopsies. European Urology Oncology. 1(3). 202–207. 16 indexed citations

17.

Taimen, Pekka, et al.. (2017). Immunological tumor status may predict response to neoadjuvant chemotherapy and outcome after radical cystectomy in bladder cancer. Scientific Reports. 7(1). 12682–12682. 15 indexed citations

18.

Boström, Peter J., Tuomas Mirtti, Bas van Rhijn, et al.. (2016). Benefit of Adjuvant Chemotherapy and Pelvic Lymph Node Dissection in pT3 and Node Positive Bladder Cancer Patients Treated with Radical Cystectomy. Bladder Cancer. 2(2). 263–272. 6 indexed citations

19.

Gu, Lei, Paraskevi Vogiatzi, Ana L. Romero-Weaver, et al.. (2014). Pharmacologic Suppression of JAK1/2 by JAK1/2 Inhibitor AZD1480 Potently Inhibits IL-6–Induced Experimental Prostate Cancer Metastases Formation. Molecular Cancer Therapeutics. 13(5). 1246–1258. 35 indexed citations

20.

Gupta, Santosh, Kristiina Iljin, Henri Sara, et al.. (2010). FZD4 as a Mediator of ERG Oncogene–Induced WNT Signaling and Epithelial-to-Mesenchymal Transition in Human Prostate Cancer Cells. Cancer Research. 70(17). 6735–6745. 217 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact